Sophia Pan | Scientist
Novartis

Sophia is a scientist in Downstream Process Development at Novartis, working on biologics drug substance development with a focus on mAb, multispecific antibodies and new modalities. She has a background in biological engineering and completed her PhD in Chemical and Biomolecular Engineering, where she engineered microbes to produce valuable chemicals, particularly isoprenoids, through metabolic engineering and synthetic biology. Her experience spans microbial cell engineering, bioprocess development, downstream purification, analytical characterization, and sustainability-related technology analysis. At Novartis, she applies her broad biotechnology background to biologics process development, process understanding, and innovation in downstream processing.